Primary Care Physicians' Use of Antipsychotics for the Treatment of Behavioural and Psychological Symptoms of Dementia in Japan

Toshiki Takayama, N. Shibata, T. Ohnuma, Koichi Miyakawa, Yoshihide Takeshita, Ayako Suzuki, Moto Nishiguchi, H. Arai
{"title":"Primary Care Physicians' Use of Antipsychotics for the Treatment of Behavioural and Psychological Symptoms of Dementia in Japan","authors":"Toshiki Takayama, N. Shibata, T. Ohnuma, Koichi Miyakawa, Yoshihide Takeshita, Ayako Suzuki, Moto Nishiguchi, H. Arai","doi":"10.14789/JMJ.2018.64.JMJ18-OA01","DOIUrl":null,"url":null,"abstract":"Objective: We aimed to investigate how primary care physicians (PCPs) in Japan use antipsychotics for treating the behavioural and psychological symptoms of dementia (BPSD). Materials and Methods: A nationwide cross-sectional online survey was conducted of PCPs who annually treated patients aged over 65 years with dementia. Responses from 509 PCPs were analysed by binominal logistic regression analysis. Results: Approximately one-third of the PCPs had treated excitatory BPSD (delusion, hallucination, agitation and violence), with half of them prescribing antipsychotics for this. Some PCPs still prescribed antipsychotics for non-excitatory BPSD, such as wandering. More than half of the PCPs had opportunities to learn about the appropriate use of antipsychotics and understood the increased mortality risk in elderly people with dementia. Referring to the Japanese Governmentʼs BPSD guideline for PCPs was negatively associated with antipsychotic dosage (odds ratio=0.491, 95% confidence intervals 0.32-0.75, p-value=0.001) and positively associated with a greater awareness of increased mortality with antipsychotics (odds ratio = 2.149, 95% confidence intervals 1.41-3.27, p-value=0.0004). Conclusion: PCPs continue to prescribe antipsychotics for excitatory BPSD in clinical practice despite official information about mortality risks. Educational material about the appropriate use of the antipsychotics should include specific mention of the risks of using antipsychotics for dementia.","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Juntendo Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14789/JMJ.2018.64.JMJ18-OA01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: We aimed to investigate how primary care physicians (PCPs) in Japan use antipsychotics for treating the behavioural and psychological symptoms of dementia (BPSD). Materials and Methods: A nationwide cross-sectional online survey was conducted of PCPs who annually treated patients aged over 65 years with dementia. Responses from 509 PCPs were analysed by binominal logistic regression analysis. Results: Approximately one-third of the PCPs had treated excitatory BPSD (delusion, hallucination, agitation and violence), with half of them prescribing antipsychotics for this. Some PCPs still prescribed antipsychotics for non-excitatory BPSD, such as wandering. More than half of the PCPs had opportunities to learn about the appropriate use of antipsychotics and understood the increased mortality risk in elderly people with dementia. Referring to the Japanese Governmentʼs BPSD guideline for PCPs was negatively associated with antipsychotic dosage (odds ratio=0.491, 95% confidence intervals 0.32-0.75, p-value=0.001) and positively associated with a greater awareness of increased mortality with antipsychotics (odds ratio = 2.149, 95% confidence intervals 1.41-3.27, p-value=0.0004). Conclusion: PCPs continue to prescribe antipsychotics for excitatory BPSD in clinical practice despite official information about mortality risks. Educational material about the appropriate use of the antipsychotics should include specific mention of the risks of using antipsychotics for dementia.
日本初级保健医生使用抗精神病药物治疗痴呆的行为和心理症状
目的:我们旨在调查日本初级保健医生(pcp)如何使用抗精神病药物治疗痴呆(BPSD)的行为和心理症状。材料和方法:对每年治疗65岁以上痴呆患者的pcp进行了全国性的横断面在线调查。采用二项logistic回归分析对509名pcp的反馈进行分析。结果:大约三分之一的pcp治疗了兴奋性BPSD(妄想、幻觉、躁动和暴力),其中一半的人为此开了抗精神病药物。一些pcp仍然给非兴奋性BPSD(如游荡)开抗精神病药。超过一半的pcp有机会了解抗精神病药物的正确使用,并了解老年痴呆症患者死亡率增加的风险。参考日本政府的BPSD指南,pcp与抗精神病药物剂量呈负相关(优势比=0.491,95%可信区间0.32-0.75,p值=0.001),与抗精神病药物死亡率增加的意识呈正相关(优势比= 2.149,95%可信区间1.41-3.27,p值=0.0004)。结论:pcp在临床实践中继续为兴奋性BPSD开抗精神病药物,尽管官方信息显示有死亡风险。关于适当使用抗精神病药物的教育材料应包括具体提及使用抗精神病药物治疗痴呆的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信